LACQW Projected Dividend Yield
Wt Exp 06/30/2022/Ensysce Biosciences Inc ( OTCBB : LACQW )Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. Co. develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant (MPAR) platform. The TAAP platform is designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription opioid drug abuse. 20 YEAR PERFORMANCE RESULTS |
LACQW Dividend History Detail LACQW Dividend News LACQW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |